Newsfeeds - Spark Newswire

7 minute read

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

Today, 9:03 AM

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.

ADAP

1 minute read

Uncategorized

10 Biggest Price Target Changes For Wednesday

By Lisa Levin

Today, 9:03 AM

HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in pre-market trading.

AMRN

13 minute read

Uncategorized

Earnings Scheduled For May 10, 2021

By Benzinga Insights

Today, 9:03 AM

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report earnings for its first quarter.

ACEL

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 9:03 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL

1 minute read

Biohaven’s Verdiperstat Receives FDA ‘May Proceed’ Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General

By Benzinga Newsdesk

Today, 9:03 AM

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) (“Biohaven” or the “Company”), a biopharmaceutical company with multiple late-stage neuroscience drug…

BHVN

Latest news

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

10 Biggest Price Target Changes For Wednesday

Earnings Scheduled For May 10, 2021

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

Biohaven’s Verdiperstat Receives FDA ‘May Proceed’ Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General